Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis
Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Systemic chemotherapy of
oxaliplatin, 5-fluorouracil and leucovorin plus lenvatinib and toripalimab in patients with
hepatocellular carcinoma with extrahepatic metastasis